Ruth Elgrably

Ruth Elgrably has extensive experience in the pharmaceutical industry, currently serving as Assistant Director and Key Account Manager at Alnylam Pharmaceuticals since April 2019, focusing on RNA silencers innovation for rare disease therapies. Prior roles include Key Account Manager at EMD Serono, with an emphasis on neuro-immunology, and Hospital Sales Representative at Janssen, specializing in endocrinology. Ruth started her career in sales management at Crucell and also held positions at Merck, where responsibilities spanned multi-channel marketing and training in the respiratory domain. Additionally, Ruth's background includes a Medical Operations Commander role in the Canadian Armed Forces, overseeing personnel and budget management. Educational qualifications include two master's degrees in Marketing and International Business from McGill University and a degree in Industrial Relations with a focus on Human Resources from Université Laval.